Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott C Borinstein

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Cancer|April 12, 2011
Investigation of the insulin-like growth factor-1 signaling pathway in localized Ewing sarcoma: a report from the Children's Oncology GroupScott C Borinstein, Donald A Barkauskas, Mark Krailo, et al.
Cancer|July 5, 2023
Consensus recommendations in the management of Ewing sarcoma from the National Ewing Sarcoma Tumor BoardAjay Gupta, Richard F Riedel, Chirag Shah, et al.
Practical Radiation Oncology|October 24, 2024
Metastatic-Site Radiation Therapy for Ewing Sarcoma and Rhabdomyosarcoma: Consensus Guidelines From the National Pediatric Cancer FoundationDana L Casey, Erin S Murphy, Colette J Shen, et al.
Plos One|July 22, 2017
Osteosarcoma enters a post genomic era with in silico opportunities: Generation of the High Dimensional Database for facilitating sarcoma biology research: A report from the Children's Oncology Group and the QuadW FoundationJason Glover, Tsz-Kwong Man, Donald A Barkauskas, et al.
Pediatric Blood & Cancer|September 15, 2017
Consensus and controversies regarding the treatment of rhabdomyosarcomaScott C Borinstein, Diana Steppan, Masanori Hayashi, et al.
Cancer Medicine|January 21, 2021
Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumorsLeo Mascarenhas, Chitose Ogawa, Theodore W Laetsch, et al.
Cancer|August 25, 2024
Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor BoardAjay Gupta, Matthew S Dietz, Richard F Riedel, et al.
JAMA Internal Medicine|June 28, 2021
Association Between a Common, Benign Genotype and Unnecessary Bone Marrow Biopsies Among African American PatientsSara L Van Driest, Noura S Abul-Husn, Joseph T Glessner, et al.
Pediatric Blood & Cancer|June 17, 2021
Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task ForceSarah B Whittle, Katharine Offer, Ryan D Roberts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2024
Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer FoundationAditi Dhir, Masanori Hayashi, Avery Bodlak, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Cancer|April 12, 2011
Investigation of the insulin-like growth factor-1 signaling pathway in localized Ewing sarcoma: a report from the Children's Oncology GroupScott C Borinstein, Donald A Barkauskas, Mark Krailo, et al.
Cancer|July 5, 2023
Consensus recommendations in the management of Ewing sarcoma from the National Ewing Sarcoma Tumor BoardAjay Gupta, Richard F Riedel, Chirag Shah, et al.
Practical Radiation Oncology|October 24, 2024
Metastatic-Site Radiation Therapy for Ewing Sarcoma and Rhabdomyosarcoma: Consensus Guidelines From the National Pediatric Cancer FoundationDana L Casey, Erin S Murphy, Colette J Shen, et al.
Plos One|July 22, 2017
Osteosarcoma enters a post genomic era with in silico opportunities: Generation of the High Dimensional Database for facilitating sarcoma biology research: A report from the Children's Oncology Group and the QuadW FoundationJason Glover, Tsz-Kwong Man, Donald A Barkauskas, et al.
Pediatric Blood & Cancer|September 15, 2017
Consensus and controversies regarding the treatment of rhabdomyosarcomaScott C Borinstein, Diana Steppan, Masanori Hayashi, et al.
Cancer Medicine|January 21, 2021
Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumorsLeo Mascarenhas, Chitose Ogawa, Theodore W Laetsch, et al.
Cancer|August 25, 2024
Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor BoardAjay Gupta, Matthew S Dietz, Richard F Riedel, et al.
JAMA Internal Medicine|June 28, 2021
Association Between a Common, Benign Genotype and Unnecessary Bone Marrow Biopsies Among African American PatientsSara L Van Driest, Noura S Abul-Husn, Joseph T Glessner, et al.
Pediatric Blood & Cancer|June 17, 2021
Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task ForceSarah B Whittle, Katharine Offer, Ryan D Roberts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2024
Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer FoundationAditi Dhir, Masanori Hayashi, Avery Bodlak, et al.
Pageof 6